PhD Dennis A. Wicherts MD

  • Citations Per Year
Learn More
Resection of breast cancer liver metastases (BCLM) combined with systemic treatment is increasingly accepted as a therapeutic option; however, the potential benefit of repeat hepatectomy for recurrent BCLM is unknown. All consecutive female patients who underwent liver resection for BCLM at our center between January 1985 and December 2012 were included.(More)
Breast cancer liver metastases (BCLM) are considered the most lethal compared with other sites of metastases in patients with breast cancer. This study aimed to evaluate the outcome after hepatectomy for BCLM within current multidisciplinary treatment and to develop a clinically useful nomogram to predict survival. Between January 1985 and December 2012,(More)
  • 1